Biotech ETFs:The Better Way to Play
October 11, 2010 at 09:00 AM EDT
As cash-strapped biotech companies see their cash reserves dwindle, it has forced a number of companies to close up shop. The struggles faced in the sector highlights the benefits of getting exposure to it through biotech exchange traded funds (ETFs). The number of publicly-traded U.S. biotech...